4,5,7‐Trisubstituted indeno[1,2‐b]indole inhibits CK2 activity in tumor cells equivalent to CX‐4945 and shows strong anti‐migratory effects
R Birus, E El‐Awaad, L Ballentin, F Alchab… - FEBS Open …, 2022 - Wiley Online Library
Highly pleiotropic and constitutively active protein kinase CK2 is a key target in cancer
therapy, but only one small‐molecule inhibitor has reached clinical trials—CX‐4945. In this …
therapy, but only one small‐molecule inhibitor has reached clinical trials—CX‐4945. In this …